Company intelligence / Profile preview
Nouveau Biosciences
New York City, New York, United Statesnouveaubiosciences.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Nouveau Biosciences has developed a proprietary nanomedicine platform that enables rapid development of targeted anti-cancer drugs. Their clinic-ready lead asset demonstrates best-in-disease activity in pancreatic cancer, AML, and T-cell malignancies. The technology improves pharmacology, tolerability, and precision of established chemistries. Preclinical results show superior efficacy over standard-of-care therapies with lower toxicity profiles
- Therapeutic areas
- Oncology
- Modalities
- Nanomedicine (polymer nanoparticles)Small molecules (delivered via nanoparticles)Drug combinations (integrated into nanoparticle delivery systems)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Longstanding relationship with a top NCI-designated Comprehensive Cancer Center in the U.S.
Beyond the preview
Go deeper on Nouveau Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nouveau Biosciences.